US study: Most doctors misunderstand e-cigarettes | Inquirer News

US study: Most doctors misunderstand e-cigarettes

By: - Contributor / @inquirerdotnet
/ 05:54 PM July 05, 2022

Tobacco Harm Reduction advocates convene in Warsaw, Poland

Tobacco Harm Reduction advocates convene in Warsaw, Poland, during the Global Forum on Nicotine 2022 to discuss how smoke-free alternatives can help people switch away from smoking cigarettes. Contributed photo

MANILA, Philippines — Most physicians have misconceptions about e-cigarettes, depriving patients with accurate information on the alternatives available to help them quit smoking, according to a major US study.

“Physicians play a primary role in patient smoking cessation, yet their communication regarding e-cigarettes is not well understood,” according to the Rutgers, The State University of New Jersey study published in the Journal of the American Medical Association (JAMA) Network Open in April.


The national cross-sectional survey asked 2,058 U.S. physicians from family medicine, internal medicine, obstetrics and gynecology, cardiology, pulmonary and oncology in 2018 and 2019 about their communication with patients about e-cigarettes. Data were analyzed from August to September 2021. JAMA is a peer-reviewed medical journal published 48 times a year by the American Medical Association.


“As the evidence base grows for e-cigarette efficacy for smoking cessation, physicians’ understanding of e-cigarettes in the context of harm reduction must keep pace with the emerging scientific evidence through effective educational opportunities.  Such opportunities should address e-cigarette safety and efficacy and correct misperceptions that all tobacco products are equally harmful,” it said.

The results of the Rutgers study are consistent with the observation of the panelists in the recent Global Forum on Nicotine (GFN) 2022 topic “Misinformation: Who can we Trust”.  The panelists said physicians and other health professionals are among those who contribute to misinformation about smoke-free products such as e-cigarettes.

“The opinion of doctors and health care professionals carry a lot of weight,” said William Stewart, president and founder of Povaddo, a US-based public opinion research firm. “When people lack information, they are more susceptible to misinformation. Tobacco harm reduction is a prime example of this.”

Stewart said a 26-country survey conducted by Povaddo showed that nearly half of those respondents wrongly believe that e-cigarettes and heated tobacco products (HTPs) are more harmful than or equally harmful as cigarettes.

He also underscored the results of a recent study showing that “the vast majority of adults say that decisions that impact society and public health should be made on the basis of science and facts”.

“Misinformation may win the sprint from time to time, but I remain confident that science and facts will ultimately win the marathon,” said Stewart.


Canadian Dr. John Oyston said there is a lot of disinformation about vaping in countries such as Canada, where the mainstream media, medical foundations and anti-tobacco groups spread misinformation about e-cigarettes.

Dr. Roberto Sussman of the National University of Mexico also said, “anti-vaping sources such as the World Health Organization, academics, regulators, anti-tobacco NGOs, groups funded by Bloomberg Philanthropies act as merchants of doubt when citing and quoting flawed studies to cast unjustified doubt and confusion on the safety of vaping”.

GFN is an international conference that focuses on how vapes, nicotine pouches, Swedish snus and HTPs can help people switch away from smoking.  This year’s GFN with the theme ‘Tobacco Harm Reduction – here for good’ was held at the Marriott in Warsaw, Poland from June 16 to 18.

The Rutgers study said that with many patients inquiring about e-cigarettes, it is important to understand the perceptions and recommendation practices of physicians as they are a trusted source of health information and are facilitators to tobacco use cessation.

It said e-cigarettes may play a pivotal role in the new US Food and Drug Administration (FDA) nicotine policy framework and thus may affect tobacco use patterns throughout the country.  Findings of the study suggest that some physicians believe e-cigarettes could help patients quit smoking in certain circumstances, but may require more evidence regarding their safety and effectiveness.

“Additionally, more than half of the physicians believed that all tobacco products are equally harmful, and this belief was associated with lower rates of recommending e-cigarettes,” it said.

Researchers from Rutgers asked how physicians would advise two different patients who wanted to quit smoking: a young woman who is a lighter smoker and had not yet tried to quit and an older man who smoked heavily and had tried to quit many times using different methods.

It found that many physicians incorrectly believe all tobacco products are equally harmful and thus are less likely to recommend e-cigarettes for people seeking to quit smoking or those being treated for a tobacco-caused disease.

This is unfortunate as data show that 480,000 Americans die each year from smoking tobacco. The study said that while the US FDA has not approved e-cigarettes as a cessation device, many people ask their physicians about using them as an alternative to tobacco cigarettes or as a way to help them stop smoking. E-cigarettes use heated liquid containing nicotine.

“As the evidence grows showing e-cigarettes as potentially effective for smoking cessation, they may play a pivotal role in reducing use of cigarettes and subsequently tobacco-caused disease,” said study author Michael Steinberg, medical director of the Rutgers Tobacco Dependence Program at the Center for Tobacco Studies and division chief in the Department of Medicine at the Rutgers Robert Wood Johnson Medical School.

“It’s important to understand physicians’ perspectives on e-cigarettes as a means for harm reduction,” said Steinberg.

The study said physicians were significantly more likely to recommend e-cigarettes for the heavy smoker while recommending US FDA-approved medications like nicotine gum or lozenges for the light smoker. Nearly 70 percent of the physicians reported that patients had asked them about e-cigarettes, and one-third said they were asked in the past 30 days. More than 60 percent of the doctors incorrectly believed that all tobacco products are equally harmful.

“These findings show it is critical to address physicians’ misperceptions and educate them on e-cigarettes’ efficacy, particularly correcting their misperceptions that all tobacco products are equally harmful, as opposed to the fact that combusted tobacco is by far the most dangerous,” said lead author Cristine Delnevo, director of the Rutgers Center for Tobacco Studies and professor of Health Behavior, Society and Policy in the Rutgers School of Public Health.

The study also found that pulmonologists, cardiologists and physicians who used the U.S. Public Health Service Clinical Practice Guidelines for treating tobacco use and dependence were more likely to recommend e-cigarettes to patients as were those who endorsed a harm-reduction perspective and had themselves smoked cigarettes. Physicians were also more likely to recommend e-cigarettes, however, if a patient asked about them first.

Other Rutgers authors in the study included Michelle Jeong, Arjun Teotia, Michelle M. Bover Manderski, Binu Singh, Mary Hrywna and Olivia A. Wackowski.


Vape bill to protect minors, save adult smokers’ lives

Physicians slam ‘strategy’ to ease vaping restrictions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Doctors ready to challenge vape bill before SC if it becomes law

TAGS: Doctors, E-cigarette, Health, lungs, Smoking, Tobacco, vape

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.